Abstract
AimsA survey of members of the UK Liver Pathology Group (UKLPG) was conducted, comprising consultant histopathologists from across the UK who report liver specimens and participate in the UK National Liver Pathology External Quality Assurance scheme. The aim of this study was to understand attitudes and priorities of liver pathologists towards digital pathology and artificial intelligence (AI).MethodsThe survey was distributed to all full consultant members of the UKLPG via email. This comprised 50 questions, with 48 multiple choice questions and 2 free-text questions at the end, covering a range of topics and concepts pertaining to the use of digital pathology and AI in liver disease.ResultsForty-two consultant histopathologists completed the survey, representing 36% of fully registered members of the UKLPG (42/116). Questions examining digital pathology showed respondents agreed with the utility of digital pathology for primary diagnosis 83% (34/41), second opinions 90% (37/41), research 85% (35/41) and training and education 95% (39/41). Fatty liver diseases were an area of demand for AI tools with 80% in agreement (33/41), followed by neoplastic liver diseases with 59% in agreement (24/41). Participants were concerned about AI development without pathologist involvement 73% (30/41), however, 63% (26/41) disagreed when asked whether AI would replace pathologists.ConclusionsThis study outlines current interest, priorities for research and concerns around digital pathology and AI for liver pathologists. The majority of UK liver pathologists are in favour of the application of digital pathology and AI in clinical practice, research and education.
Funder
National Institute For Health Research (NIHR) UCLH/UCL Biomedical Research Centre
Leeds Hospitals Charity
National Institute for Health Research
National Pathology Imaging Cooperative
Subject
General Medicine,Pathology and Forensic Medicine
Reference27 articles.
1. Burden of liver diseases in the world
2. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies;Pimpin;J Hepatol,2018
3. Public Health England. . Liver disease profiles: short statistical commentary, 2018. Available: https://www.gov.uk/government/statistics/liver-disease-profiles-november-2018-update/liver-disease-profiles-short-statistical-commentary-november-2018 [Accessed Aug 2022].
4. Liver biopsy;Bedossa;Gastroenterol Clin Biol,2008
5. The evolving role of liver biopsy
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献